Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)
Mil. med. res. (Lond.); 7 (41), 2020
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Quimioprevenção/métodos, Infecções por Coronavirus/diagnóstico, Infecções por Coronavirus/tratamento farmacológico, Pneumonia Viral/diagnóstico, Pneumonia Viral/tratamento farmacológico, Pandemias/prevenção & controle, Betacoronavirus/efeitos dos fármacos, Prática Clínica Baseada em Evidências/métodos, Antirretrovirais/uso terapêutico, Lopinavir/uso terapêutico, Cloroquina/uso terapêutico, Receptores de Interleucina-6/uso terapêutico, Hidroxicloroquina/uso terapêutico, Plasma/imunologia